These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 11840268

  • 1. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
    Marone M, Scambia G, Bonanno G, Rutella S, de Ritis D, Guidi F, Leone G, Pierelli L.
    Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor-beta1 causes transcriptional activation of CD34 and preserves haematopoietic stem/progenitor cell activity.
    Pierelli L, Marone M, Bonanno G, Rutella S, de Ritis D, Mancuso S, Leone G, Scambia G.
    Br J Haematol; 2002 Aug; 118(2):627-37. PubMed ID: 12139758
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG.
    Oncogene; 2003 Jul 10; 22(28):4314-32. PubMed ID: 12853969
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
    Kalina U, Koschmieder S, Hofmann WK, Wagner S, Kauschat D, Hoelzer D, Ottmann OG.
    Exp Hematol; 2001 May 10; 29(5):602-8. PubMed ID: 11376873
    [Abstract] [Full Text] [Related]

  • 5. TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34+ cells from healthy donors, but not from patients with AML after MDS.
    Koschmieder S, Hofmann WK, Kunert J, Wagner S, Ballas K, Seipelt G, Hoelzer D, Ottmann OG, Kalina U.
    Leukemia; 2001 Jun 10; 15(6):942-9. PubMed ID: 11417481
    [Abstract] [Full Text] [Related]

  • 6. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts.
    Suzuki H, Uchida K, Nitta K, Nihei H.
    Clin Exp Nephrol; 2004 Sep 10; 8(3):188-95. PubMed ID: 15480895
    [Abstract] [Full Text] [Related]

  • 7. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts.
    Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, Nakazawa T, Mori M.
    Am J Respir Cell Mol Biol; 2003 Jun 10; 28(6):754-61. PubMed ID: 12760970
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
    Edlund S, Bu S, Schuster N, Aspenström P, Heuchel R, Heldin NE, ten Dijke P, Heldin CH, Landström M.
    Mol Biol Cell; 2003 Feb 10; 14(2):529-44. PubMed ID: 12589052
    [Abstract] [Full Text] [Related]

  • 9. p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion.
    Hayes SA, Huang X, Kambhampati S, Platanias LC, Bergan RC.
    Oncogene; 2003 Jul 31; 22(31):4841-50. PubMed ID: 12894225
    [Abstract] [Full Text] [Related]

  • 10. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
    Kim HS, Luo L, Pflugfelder SC, Li DQ.
    Invest Ophthalmol Vis Sci; 2005 Mar 31; 46(3):840-8. PubMed ID: 15728539
    [Abstract] [Full Text] [Related]

  • 11. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis.
    Verma A, Deb DK, Sassano A, Uddin S, Varga J, Wickrema A, Platanias LC.
    J Biol Chem; 2002 Mar 08; 277(10):7726-35. PubMed ID: 11773065
    [Abstract] [Full Text] [Related]

  • 12. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.
    Watanabe H, de Caestecker MP, Yamada Y.
    J Biol Chem; 2001 Apr 27; 276(17):14466-73. PubMed ID: 11278290
    [Abstract] [Full Text] [Related]

  • 13. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
    Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F.
    Eur J Haematol; 2001 Aug 27; 67(2):63-71. PubMed ID: 11722592
    [Abstract] [Full Text] [Related]

  • 14. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
    Kim HP, Lee MS, Yu J, Park JA, Jong HS, Kim TY, Lee JW, Bang YJ.
    Biochem J; 2004 Apr 01; 379(Pt 1):141-50. PubMed ID: 14720123
    [Abstract] [Full Text] [Related]

  • 15. Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells.
    Cao Z, Flanders KC, Bertolette D, Lyakh LA, Wurthner JU, Parks WT, Letterio JJ, Ruscetti FW, Roberts AB.
    Blood; 2003 Jan 15; 101(2):498-507. PubMed ID: 12393416
    [Abstract] [Full Text] [Related]

  • 16. p38 MAP kinase regulation of AP-2 binding in TGF-beta1-stimulated chondrogenesis of human trabecular bone-derived cells.
    Tuli R, Seghatoleslami MR, Tuli S, Howard MS, Danielson KG, Tuan RS.
    Ann N Y Acad Sci; 2002 Jun 15; 961():172-7. PubMed ID: 12081893
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling.
    Dai C, Yang J, Liu Y.
    J Biol Chem; 2003 Apr 04; 278(14):12537-45. PubMed ID: 12560323
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells.
    Ducos K, Panterne B, Fortunel N, Hatzfeld A, Monier MN, Hatzfeld J.
    J Cell Physiol; 2000 Jul 04; 184(1):80-5. PubMed ID: 10825236
    [Abstract] [Full Text] [Related]

  • 20. Molecular mechanisms behind the dose-dependent differential activation of MAPK pathways induced by transforming growth factor-beta1 in hematopoietic cells.
    Kale VP, Vaidya AA.
    Stem Cells Dev; 2004 Oct 04; 13(5):536-47. PubMed ID: 15588511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.